We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$729M
AUM Growth
+$63.7M
Cap. Flow
+$10.4M
Cap. Flow %
1.42%
Top 10 Hldgs %
28.18%
Holding
206
New
12
Increased
105
Reduced
63
Closed
2

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$1.85M
2
OKE icon
Oneok
OKE
+$1.67M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.46M
4
CTSH icon
Cognizant
CTSH
+$1.22M
5
ADBE icon
Adobe
ADBE
+$1.22M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.76M
2
IBM icon
IBM
IBM
+$3.53M
3
MYGN icon
Myriad Genetics
MYGN
+$1.31M
4
TGT icon
Target
TGT
+$1.13M
5
CTXS
Citrix Systems Inc
CTXS
+$1.08M

Sector Composition

Rank Sector Weight
1 Healthcare 22.98%
2 Industrials 11.55%
3 Energy 11.36%
4 Consumer Staples 10.91%
5 Technology 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
201
Waste Management
WM
$90.6B
$211K 0.03%
+4,700
New +$205K
CFR icon
202
Cullen/Frost Bankers
CFR
$10.3B
$201K 0.03%
+2,700
New +$193K
PBCT
203
DELISTED
People's United Financial Inc
PBCT
$199K 0.03%
13,131
MYGN icon
204
Myriad Genetics
MYGN
$270M
-55,834
Closed -$1.31M
SPLS
205
DELISTED
Staples Inc
SPLS
-10,155
Closed -$149K

Similar funds

Boston Financial Management's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Financial Management held 206 positions worth $729M, up 9.6% from $666M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Financial Management's Q4 2013 filing shows 12 new, 105 increased, 63 reduced and 2 closed positions. Its largest new stake was American Tower: 23,815 shares worth $1.9M. The largest sale was Pfizer, an estimated $6.76M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Energy.

  • Boston Financial Management's largest Q4 2013 buy was American Tower: 23,815 shares worth $1.9M.
  • Boston Financial Management added most to Oneok in Q4 2013, an estimated $1.67M increase.
  • Boston Financial Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $6.76M.
  • Boston Financial Management fully exited Myriad Genetics in Q4 2013, selling an estimated $1.31M.
  • Boston Financial Management's ten largest holdings make up 28% of its $729M portfolio in Q4 2013.
  • Boston Financial Management opened 12 new positions and closed 2 in Q4 2013.
  • Boston Financial Management's portfolio value rose 9.6% quarter-over-quarter to $729M.

Based on Boston Financial Management's 13F filing for Q4 2013, filed 25 Feb 2014.